Some Google Adwords in violation of FDA rules

Pharma Marketing Blog takes a look at how some drug advertising using Google Adwords is in violation of FDA rules:

What the ad doesn’t tell you — and what the FDA requires all drug ads that mention the brand name and the indication or benefits to tell you — is the major side effects. Or at least provide a direct link to a brief summary of the product labeling as in the Rozerem ad shown on the left. In this ad all you need to do to get the required information is to roll your mouse over the appropriately labeled area. Even so, this ad may also have been violative if it mentioned the indication because mouse rollovers may not be considered “fair balance” by the FDA. The Rozerem ad shown on the left and the Rozerem Adword shown above do not mention sleep, so they are fine as far as the FDA is concerned.

Related posts:

1. Pfizer’s Adwords run afoul of FDA regulations
2. Google and Microsoft Health
3. James Kim and privacy rules: Can HIPAA also lead to needless deaths?
4. A genetic test for Coumadin
5. How the government is regulating prescribing practices
6. Knowing costs can be an EMTALA violation
7. Google on health

  Follow on Twitter   Subscribe